JPWO2022264033A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2022264033A5
JPWO2022264033A5 JP2023577490A JP2023577490A JPWO2022264033A5 JP WO2022264033 A5 JPWO2022264033 A5 JP WO2022264033A5 JP 2023577490 A JP2023577490 A JP 2023577490A JP 2023577490 A JP2023577490 A JP 2023577490A JP WO2022264033 A5 JPWO2022264033 A5 JP WO2022264033A5
Authority
JP
Japan
Prior art keywords
cells
concentration
cell population
cell
culture medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023577490A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024523332A (ja
JP2024523332A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/055504 external-priority patent/WO2022264033A1/en
Publication of JP2024523332A publication Critical patent/JP2024523332A/ja
Publication of JPWO2022264033A5 publication Critical patent/JPWO2022264033A5/ja
Publication of JP2024523332A5 publication Critical patent/JP2024523332A5/ja
Pending legal-status Critical Current

Links

JP2023577490A 2021-06-15 2022-06-14 多能性幹細胞からナチュラルキラー細胞を産生するための方法 Pending JP2024523332A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163210683P 2021-06-15 2021-06-15
US63/210,683 2021-06-15
PCT/IB2022/055504 WO2022264033A1 (en) 2021-06-15 2022-06-14 Method for producing natural killer cells from pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2024523332A JP2024523332A (ja) 2024-06-28
JPWO2022264033A5 true JPWO2022264033A5 (https=) 2025-06-19
JP2024523332A5 JP2024523332A5 (https=) 2025-06-19

Family

ID=82656646

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023577490A Pending JP2024523332A (ja) 2021-06-15 2022-06-14 多能性幹細胞からナチュラルキラー細胞を産生するための方法

Country Status (13)

Country Link
US (1) US20240108656A1 (https=)
EP (1) EP4355861A1 (https=)
JP (1) JP2024523332A (https=)
KR (1) KR20240021878A (https=)
CN (1) CN117813374A (https=)
AR (1) AR126145A1 (https=)
AU (1) AU2022292988A1 (https=)
BR (1) BR112023026141A2 (https=)
CA (1) CA3222770A1 (https=)
CO (1) CO2023018654A2 (https=)
MX (1) MX2023014979A (https=)
TW (1) TW202317755A (https=)
WO (1) WO2022264033A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202600815A (zh) * 2024-03-05 2026-01-01 美商Ｒ Ｐ 先靈爾科技公司 將多能幹細胞分化成自然殺手細胞之方法

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
BRPI0619794B8 (pt) 2005-12-13 2022-06-14 Univ Kyoto Uso de um fator de reprogramação, agente para a preparação de uma célula-tronco pluripotente induzida a partir de uma célula somática e métodos para preparar uma célula- tronco pluripotente induzida método e para preparar uma célula somática e uso de células-tronco pluripotentes induzidas
DK3399025T3 (da) 2007-03-23 2025-06-16 Wisconsin Alumni Res Found Omprogrammering af somatiske celler
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
AU2008297011B2 (en) 2007-08-31 2014-06-12 Whitehead Institute For Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
US20100330063A1 (en) 2007-12-17 2010-12-30 Gliamed, Inc. Stem-like cells, method for de-differentiating mammalian somatic cells into stem-like cells, and method for differentiating stem-like cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
US20110014164A1 (en) 2008-02-15 2011-01-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
SG188904A1 (en) 2008-03-17 2013-04-30 Scripps Research Inst Combined chemical and genetic approaches for generation of induced pluripotent stem cells
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
AU2009234424A1 (en) 2008-04-07 2009-10-15 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an HDAC modulator
CA2695590C (en) 2008-06-27 2018-01-09 Kyoto University Method of efficiently establishing induced pluripotent stem cells
EP2313494A2 (en) 2008-07-14 2011-04-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/arid3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
WO2010050626A1 (en) 2008-10-30 2010-05-06 Kyoto University Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
US9045737B2 (en) 2008-12-13 2015-06-02 Dnamicroarray, Inc. Artificial three-dimensional microenvironment niche culture
JP5553289B2 (ja) 2009-02-27 2014-07-16 国立大学法人京都大学 新規核初期化物質
WO2010102267A2 (en) 2009-03-06 2010-09-10 Ipierian, Inc. Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111422A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
US20110088107A1 (en) 2009-04-24 2011-04-14 Yaqub Hanna Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
UY35468A (es) 2013-03-16 2014-10-31 Novartis Ag Tratamiento de cáncer utilizando un receptor quimérico de antígeno anti-cd19
AU2016211671B2 (en) * 2015-01-26 2022-05-26 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
CA3003152A1 (en) * 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2018195175A1 (en) * 2017-04-18 2018-10-25 FUJIFILM Cellular Dynamics, Inc. Antigen-specific immune effector cells

Similar Documents

Publication Publication Date Title
CN111235105B (zh) 一种从人多能干细胞分化为自然杀伤细胞的方法及应用
Yamaguchi et al. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells
Bagley et al. Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device
AU699479B2 (en) Use of stem cell factor and soluble interleukin-6 receptor for the ex vivo expansion of hematopoietic multipotential cells
KR101803562B1 (ko) 다능성 줄기세포로부터 유도된 탈핵 적혈구계 세포를 생산하는 방법
Sandstrom et al. Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells
Douay Experimental culture conditions are critical for ex vivo expansion of hematopoietic cells
Mehta et al. Novel techniques for ex vivo expansion of cord blood: clinical trials
US20050272152A1 (en) Stem cell populations and methods of use
EP3567102A1 (en) Method for developing natural killer cells from stem cells
Ehring et al. Expansion of HPCs from cord blood in a novel 3D matrix
AU2004234627A1 (en) Apparatus and methods for amplification of blood stem cell numbers
Kanai et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity
JPWO2021174004A5 (https=)
Ando et al. Extensive generation of human cord blood CD34+ stem cells from Lin− CD34− cells in a long-term in vitro system
WO2025077137A1 (zh) 一种制备造血干细胞和祖细胞的方法
CN117683713A (zh) 利用人多潜能干细胞体外制备t淋巴细胞和nk细胞
Alcorn et al. Ex vivo expansion of haemopoietic progenitor cells
JPWO2022264033A5 (https=)
Kawai et al. Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling
RU2023133748A (ru) Способ получения естественных клеток-киллеров из плюрипотентных стволовых клеток
Ziegler et al. Expansion of stem and progenitor cells
JP2024506313A (ja) 多能性幹細胞由来の造血性内皮細胞からのリンパ球系細胞の分化方法
McAdams et al. Ex vivo expansion of primitive hematopoietic cells for cellular therapies: An overview
von Drygalski et al. Placental/umbilical cord blood (PCB) stem cells for transplantation: early clinical outcomes and the status of ex vivo expansion strategies